Home -> Law Blog Directory -> Patent Law Blogs -> Patent Baristas
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent BaristasPfizer Feels Pain Over Celebrex
By Stephen Albainy-Jenei
ADVERTISEMENTS
The Court of Appeals for the Federal Circuit upheld a lower court ruling that Teva Pharmaceutical Industries Ltd. infringed two patents held by Pfizer Inc. for Celebrex, a non-steroidal anti-inflammatory drug (NSAID) used to treat osteoarthritis and rheumatoid arthritis. Pfizer v. Teva (07-1271).
Pfizer has three patents listed in the FDA’s Orange Book protecting its arthritis drug Celebrex (celecoxib), selective non-steroidal anti-inflammatory drug used to treat pain and inflammation. Pfi read more
Full post as published by Patent Baristas on March 20, 2008 (boomark / email).
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

Bextra, Celebrex Cases Are Settling
Pfizer settles Bextra, Celebrex personal injury lawsuits
Federal Circuit Invalidates Pfizer's Latest-Expiring Patent on Celebrex, for Double Patenting
Lawsuit Against Pfizer over Celebrex and Bextra Continues
Pfizer Strikes Some Tentative Settlements in Bextra and Celebrex Cases
Pfizer to Hire Amy Schulman as Next General Counsel








